Gives gemcitabin derimod hver 3. eller 4. dag, kan det gives i ikke- letale doser, med betydelig antitumoraktivitet mod et bredt spektrum af musetumorer.
If, however, gemcitabine is given every third or fourth day, it can be administered in non- lethal doses with substantial antitumoural activity against a broad spectrum of mouse tumours.